Paul-Emmanuel Goethals founded CSIntell in 2012 followed by MEDraysintell in 2013. He has 35 years of experience in consulting, business development-intelligence and investor relations with a unique understanding of the medical and healthcare markets, especially in Radiotherapy, Radiopharmacy. Throughout these years he made numerous reports on complex markets as well as outstanding company profiles at the full satisfaction of his successive clients.

Paul-Emmanuel holds an MBA from the University of Dallas and is a member of SCIP (Strategic and Competitive Intelligence Professionals, Texas, USA).

Prior founding MEDraysintell and CSIntell, Paul-Emmanuel was Vice President Business Development & Capital Markets and Special Counsel to the CEO at Eckert & Ziegler Group, a European group listed in Frankfurt, active in cancer therapy, radiometry, nuclear-medical imaging (2009-2012); Director Corporate Business Development & Investor Relations at IBA, a Belgian company listed in Brussels, active in Proton Therapy, Radiopharmacy, Dosimetry and Industrial Sterilization (1998-2009); Project Manager at Strategic Analysis Inc., a US management consulting firm active in Chemical and Pharmaceutical Business Intelligence (1994 - 1998); Finance Director & Board member at Evening Group SA, a Belgian company active in business events (1992-1993) and Marketing Specialist & Product Management at Chemviron Carbon, the European branch of a US chemical group (1989-1992).